| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |
| 04/21/2004 | EP1409675A1 Gene involved in apoptosis regulation |
| 04/21/2004 | EP1409673A2 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 04/21/2004 | EP1409662A1 Allene oxide synthase and divinyl ether synthase from the cyp74-enzyme family isolated out of physcomitrella patens, the nucleotide sequences that code these synthases, and method for producing pathogen-resistant plants |
| 04/21/2004 | EP1409661A2 Hdac9 polypeptides and polynucleotides and uses thereof |
| 04/21/2004 | EP1409660A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof |
| 04/21/2004 | EP1409659A2 Subtilase variants |
| 04/21/2004 | EP1409658A2 Aggrecanase molecules |
| 04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
| 04/21/2004 | EP1409652A2 Immortalized preosteoblasts and method for their production |
| 04/21/2004 | EP1409651A2 Method for producing isolated cell cultures, culture medium for cultivating cell cultures and cell culture |
| 04/21/2004 | EP1409650A1 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
| 04/21/2004 | EP1409649A2 Two chamber cell culture vessel |
| 04/21/2004 | EP1409648A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions |
| 04/21/2004 | EP1409647A2 Composite scaffolds and methods using same for generating complex tissue grafts |
| 04/21/2004 | EP1409646A2 Transgenic animals comprising a humanized immune system |
| 04/21/2004 | EP1409639A1 Epidermal growth factor receptorantisense oligonucleotides |
| 04/21/2004 | EP1409550A1 Extracellular messengers |
| 04/21/2004 | EP1409547A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 04/21/2004 | EP1409546A2 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 04/21/2004 | EP1409545A2 Allelic variants of grp50 |
| 04/21/2004 | EP1409544A2 Human dr4 antibodies and uses thereof |
| 04/21/2004 | EP1409542A2 Blood group antigen fusion polypeptides and methods of use thereof |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409527A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 04/21/2004 | EP1409523A2 Pancam nucleic acids and polypeptides |
| 04/21/2004 | EP1409517A2 Fusion proteins based upon somatostatin receptors |
| 04/21/2004 | EP1409456A2 Detection of transmembrane potentials by optical methods |
| 04/21/2004 | EP1409025A1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1408909A2 Improved conditionally replicating vectors for inhibiting viral infections |
| 04/21/2004 | EP1408908A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 04/21/2004 | EP1408811A2 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 04/21/2004 | EP1408808A2 Methods for diagnosing and treating heart disease |
| 04/21/2004 | EP1408753A2 Compounds effecting neuron remodeling and assays for same |
| 04/21/2004 | EP1232396B1 Assay of isomerised and/or optically inverted proteins |
| 04/21/2004 | EP1159004A4 Novel redox clamping agents and uses thereof |
| 04/21/2004 | EP1053301B1 A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use |
| 04/21/2004 | EP0859847B1 Composition and method of imparting resistivity to hiv superinfection to cells |
| 04/21/2004 | EP0836647B1 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/21/2004 | EP0815218B1 Human vegf-specific antisense oligonucleotides |
| 04/21/2004 | CN1491281A Neurotonin and use thereof |
| 04/21/2004 | CN1491278A Lipase variants |
| 04/21/2004 | CN1491116A Hepatitis B virus treatment |
| 04/21/2004 | CN1490404A Human high metas tasis breast cancer cell line and setting method thereof |
| 04/21/2004 | CN1490403A Human inflammatory mammary cancer cell lines and its establishment |
| 04/21/2004 | CN1490402A Culturing method for 'cell-tissue' |
| 04/21/2004 | CN1490401A Low freedom energy surface microprocessing method for controlling cell positioning and use thereof |
| 04/21/2004 | CN1490400A Micro-carpillary tube covering method for controlling cell special distribution in shape and size, and use thereof |
| 04/21/2004 | CN1490399A Method for forming block from divided sponge organs |
| 04/21/2004 | CN1490056A Immune method and composition for HIV-1 |
| 04/21/2004 | CN1490049A CD26/DPP IV application for medicine in preparing treatment and/or diagnostic disease |
| 04/21/2004 | CN1146663C Selection marker |
| 04/21/2004 | CN1146442C Lympha toxin-alpha/beta compositions as anti tumor agent and antilympha toxin beta receptor antibody |
| 04/21/2004 | CN1146440C Vascular endothelial growth factor-B |
| 04/21/2004 | CA2463439A1 A delivery system |
| 04/20/2004 | US6723841 Corticotropin-releasing factor2 receptors |
| 04/20/2004 | US6723832 Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
| 04/20/2004 | US6723567 Screening method for apoptosis and necrosis |
| 04/20/2004 | US6723561 Polypeptides |
| 04/20/2004 | US6723555 Multi-sample fermentor and method of using same |
| 04/20/2004 | US6723552 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 04/20/2004 | US6723546 Method for cloning and expression of BsaI restriction endonuclease and BsaI methylase in E. coli |
| 04/20/2004 | US6723543 Mutant kanamycin nucleotidyltransferases from S. aureus |
| 04/20/2004 | US6723532 Plasmid for use in gene therapy |
| 04/20/2004 | US6723519 Compositions and method for determining the presence of rat PTTG peptide in a sample |
| 04/20/2004 | US6723511 Suppression of apoptosis in cell; obtain cells, incubate with blocking agent, monitor apoptosis in cells |
| 04/16/2004 | CA2444468A1 A composition for the culture of cells, in particular animal cells or tissues, comprising polyethylene glycol |
| 04/15/2004 | WO2004031415A2 Methods and compositions for rapid development of screening assays nuclear receptors |
| 04/15/2004 | WO2004031388A1 Factor participating in transcriptional regulation |
| 04/15/2004 | WO2004031383A1 High yield heterologous expression cell lines for expression of gene products with human glycosylation pattern |
| 04/15/2004 | WO2004031373A1 Method of constructing differentiated cells |
| 04/15/2004 | WO2004031371A2 Programmable scaffold and methods for making and using the same |
| 04/15/2004 | WO2004031370A1 Procedure for the large-scale t-lymphocytes culture in a homogeneous system |
| 04/15/2004 | WO2004031369A1 Cell culture |
| 04/15/2004 | WO2004031367A2 Uses of human zven proteins and polynucleotides |
| 04/15/2004 | WO2004031361A2 Three-dimensional peripheral lymphoid organ cell cultures |
| 04/15/2004 | WO2004031343A2 Human foreskin cells suitable for culturing stem cells |
| 04/15/2004 | WO2004031276A2 Method of inducing maturation of dendritic cells and uses therefor |
| 04/15/2004 | WO2004031266A2 Cell adhesion resisting surfaces |
| 04/15/2004 | WO2004031227A1 Transcriptional activator gene for genes involved in cobalamin biosynthesis |
| 04/15/2004 | WO2004031224A2 Hbv mutations associated with reduced susceptibility to adefovir |
| 04/15/2004 | WO2004030706A2 Bioactive implants |
| 04/15/2004 | WO2004030628A2 Adult bone marrow derived stem cells |
| 04/15/2004 | WO2004030626A2 In vitro culture of tissue structures |
| 04/15/2004 | WO2004011632A3 Oligodendrocyte production from multipotent neural stem cells |
| 04/15/2004 | WO2004011629A3 Immortalized colon epithelial cells and the use thereof |
| 04/15/2004 | WO2004004451B1 Methods of screening compounds for grk6 modulating activity |
| 04/15/2004 | WO2004003209A3 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 04/15/2004 | WO2004003181A3 Method for preparing animal or human adult stem cells and therapeutic use thereof |
| 04/15/2004 | WO2003106488A3 Antagonists of cxr3-binding cxc chemokines |
| 04/15/2004 | WO2003103581A3 Compositions and methods for liver growth and liver protection |
| 04/15/2004 | WO2003091266A3 Protein stabilisation using chaperone proteins |
| 04/15/2004 | WO2003084431A3 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering |
| 04/15/2004 | WO2003070752A3 Mhc-peptide complex binding ligands |
| 04/15/2004 | WO2003061591A3 Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
| 04/15/2004 | WO2003059951A3 Novel anti-igf-ir antibodies and uses thereof |
| 04/15/2004 | WO2003056899A9 Nitric oxide donors for treatment of disease and injury |
| 04/15/2004 | WO2003054212A8 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 04/15/2004 | WO2003050250B1 Chondrocyte precursors derived from human embryonic stem cells |